David C. Fajgenbaum

International, evidence-based consensus diagnostic criteria for HHV-8–negative/idiopathic multicentric Castleman disease

David C. Fajgenbaum, Thomas S. Uldrick, Adam Bagg et al. · Blood · 2017 · 624 citations · Full text

Life Sciences, Hematology, Virology +4

International, evidence-based consensus treatment guidelines for idiopathic multicentric Castleman disease

Frits van Rhee, Peter M. Voorhees, Angela Dispenzieri et al. · Blood · 2018 · 414 citations · Full text

Medicine, Internal Medicine, Integrated Disease Management +4

Clinicopathologic analysis of <scp>TAFRO</scp> syndrome demonstrates a distinct subtype of <scp>HHV</scp>‐8‐negative multicentric Castleman disease

Noriko Iwaki, David C. Fajgenbaum, Christopher S. Nabel et al. · American Journal of Hematology · 2015 · 285 citations · Full text

Medicine, Immunology, Pathology +10

International evidence-based consensus diagnostic and treatment guidelines for unicentric Castleman disease

Frits van Rhee, Éric Oksenhendler, Gordan Srkalović et al. · Blood Advances · 2020 · 216 citations · Full text

Medicine, Oncology, Pathology +13

The full spectrum of Castleman disease: 273 patients studied over 20 years

Éric Oksenhendler, David Boutboul, David C. Fajgenbaum et al. · British Journal of Haematology · 2017 · 205 citations

Medicine, Oncology, Pathology +12